CAS 29868-97-1
:Pirenzepinhydrochlorid
- 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one dihydrochloride
- 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one hydrate hydrochloride
- 5,11-Dihydro-11-((4-methylpiperazin-1-yl)acetyl)-6H-pyrido(2,3-b)-(1,4)benzodiazepin-6-one dihydrochloride
- 5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one dihydrochloride
- 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-, dihydrochloride
- 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-, hydrochloride (1:2)
- Duogastral
- Durapirenz
- Gasteril
- Gastricur
- Gastrozepin
- L-S 519
- LS 519Cl<sub>2</sub>
- LS 59Cl2
- Leblon
- Maghen
- Pirenzepine HCL
- Pirenzepine Hcl Hydrate
- Pirenzepine Hydrochloride
- Renzepin
- Ulcosan
- Ulcuforton
- Weitere Synonyme anzeigen
Pirenzepine Dihydrochloride
CAS:Formel:C19H21N5O2·2HClReinheit:>98.0%(T)(HPLC)Farbe und Form:White to Yellow to Orange powder to crystalMolekulargewicht:424.33Pirenzepine dihydrochloride, 99%
CAS:A M1 muscarinic receptor antagonistFormel:C19H23Cl2N5O2Reinheit:99%Farbe und Form:Crystals or powder or crystalline powder, White to pale yellowMolekulargewicht:424.33PIRENZEPINE DIHYDROCHLORIDE MONOHYDRATE CRS
CAS:PIRENZEPINE DIHYDROCHLORIDE MONOHYDRATE CRSFormel:C19H23Cl2N5O2Farbe und Form:Crystalline Powder. White. Light Yellow. Powder., Crystalline Powder. White. Light Yellow. Powder.Molekulargewicht:424.3242Pirenzepine dihydrochloride
CAS:Pirenzepine dihydrochloride (LS519) is a selective M1 muscarinic receptor antagonist, inhibiting gastric secretion.Formel:C19H21N5O2·2HClReinheit:99.48% - 99.62%Farbe und Form:White PowderMolekulargewicht:424.32Pirenzepine dihydrochloride
CAS:Formel:C19H21N5O2·2HClReinheit:98.0 - 102.0 % (dried basis)Farbe und Form:White to off-white or pale yellow powderMolekulargewicht:424.32Pirenzepine, Dihydrochloride
CAS:Kontrolliertes ProduktApplications An antiulcerative. Tricyclic gastric-acid inhibitor.
References Eberlein, W., et al.: Arzneimittel-Forsch., 27, 356 (1977), Hellerr, G., et al.: Verh. Deut. Ges. Inn. Med., 84, 991 (1978), Carmine, A.A., et al.: Drugs, 30,85 (1985), El-Obeid, H.A., et al.: Anal. Profiles Drug Subs., 16, 445 (1987), Homon, C.A., et al.: Ther. Drug Monit., 9, 236 (1987),Formel:C19H21N5O2·2ClHFarbe und Form:NeatMolekulargewicht:424.32Pirenzepine-d8 Dihydrochloride
CAS:Kontrolliertes ProduktFormel:C19H15D8Cl2N5O2Farbe und Form:NeatMolekulargewicht:432.37Pirenzepine dihydrochloride
CAS:Pirenzepine is a nonsteroidal anti-inflammatory drug and prokinetic agent used to treat bowel disease. It is also used to treat pancreatic enzyme deficiency, which can result in chronic diarrhea. Pirenzepine has been shown to inhibit protease activity in mouse serum, and it has been reported that this inhibition may be due to its ability to bind with amyloid protein and prevent amyloid aggregation. Pirenzepine also suppresses inflammatory responses by inhibiting the production of inflammatory mediators such as leukotrienes, prostaglandins, and cytokines, thereby providing therapeutic benefits for treating chronic bronchitis and other inflammatory diseases. Pirenzepine is metabolized in the liver by the cytochrome P450 enzyme system into an active form called pirenzepine N-oxide. This active form is then metabolized by hydrolysis or glucuronidation before excretion from the body. The most common sideFormel:C19H23Cl2N5O2Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:424.32 g/molPirenzepine-d10 Dihydrochloride
CAS:Kontrolliertes ProduktApplications Pirenzepine-d10 Dihydrochloride is an analogue of Pirenzepine (P508500), an antiucerative agent that works by inhibiting tricyclic gastric-acid secretion.
References Fliri, A . F., et al.: J. Med. Chem., 52, 8038 (2009); Eberlein, W., et al.: Arzneimittel-Forsch., 27, 356 (1977), Hellerr, G., et al.: Verh. Deut. Ges. Inn. Med., 84, 991 (1978), Carmine, A.A., et al.: Drugs, 30,85 (1985), El-Obeid, H.A., et al.: Anal. Profiles Drug Subs., 16, 445 (1987), Homon, C.A., et al.: Ther. Drug Monit., 9, 236 (1987),Formel:C19H12D11Cl2N5O2Farbe und Form:BrownMolekulargewicht:435.39









